Lakeside Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Buy
10,293
+203
+2% +$5.31K 0.16% 62
2026
Q1
$283K Buy
10,090
+4
+0% +$106 0.19% 59
2025
Q4
$251K Sell
10,086
-896
-8% -$22.6K 0.16% 57
2025
Q3
$280K Sell
10,982
-497
-4% -$12.3K 0.18% 54
2025
Q2
$278K Buy
11,479
+4
+0% +$93 0.18% 55
2025
Q1
$291K Buy
11,475
+104
+0.9% +$2.72K 0.19% 53
2024
Q4
$302K Buy
11,371
+1,553
+16% +$42.1K 0.2% 54
2024
Q3
$284K Buy
9,818
+1,003
+11% +$29.3K 0.18% 59
2024
Q2
$247K Buy
8,815
+303
+4% +$8.34K 0.16% 59
2024
Q1
$236K Sell
8,512
-1,000
-11% -$27.7K 0.15% 58
2023
Q4
$274K Buy
9,512
+3,000
+46% +$90.7K 0.19% 55
2023
Q3
$216K Buy
6,512
+1,000
+18% +$35.4K 0.17% 57
2023
Q2
$202K Hold
5,512
0.15% 58
2023
Q1
$225K Hold
5,512
0.17% 54
2022
Q4
$282K Hold
5,512
0.23% 48
2022
Q3
$241K Hold
5,512
0.22% 51
2022
Q2
$289K Hold
5,512
0.25% 47
2022
Q1
$285K Hold
5,512
0.22% 48
2021
Q4
$325K Buy
+5,512
New +$273K 0.24% 41

Other funds holding PFE

Lakeside Advisors's PFE Position: Q2 2026 in Review

Lakeside Advisors increased its Pfizer (PFE) stake by 2% in Q2 2026, buying an estimated $5.31K and bringing the position to 10,293 shares worth $248K. The position accounts for 0.16% of the portfolio, ranked #62.

Lakeside Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $325K in Q4 2021. 1,596 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Lakeside Advisors held 10,293 shares of Pfizer worth $248K as of Q2 2026.
  • Lakeside Advisors bought 203 Pfizer shares in Q2 2026, an estimated $5.31K.
  • Pfizer made up 0.16% of Lakeside Advisors's portfolio in Q2 2026, its #62 holding.
  • Lakeside Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Lakeside Advisors's Pfizer position peaked at $325K in Q4 2021.
  • 1,596 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lakeside Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.